Correlation of plasma interleukin-18 concentration and severity of renal involvement and disease activity in systemic lupus erythematosus

Mohammad Reza Jafari-Nakhjavani ¹, Sima Abedi-Azar ² * , Babak Nejati ¹

Cited by CrossRef: 23

1- Wu J, Zhang X, Wu D, Jin O, Gu J. Evaluation of causal associations between interleukin-18 levels and immune-mediated inflammatory diseases: a Mendelian randomization study. BMC Med Genomics. 2023;16(1) [Crossref]

2- Umare V, Pradhan V, Nath S, Rajadhyaksha A, Ghosh K, Nadkarni A. Impact of functional IL-18 polymorphisms on genetic predisposition and diverse clinical manifestations of the disease in Indian SLE patients. Lupus. 2019;28(4):545 [Crossref]

3- Aringer M. Inflammatory markers in systemic lupus erythematosus. Journal of Autoimmunity. 2020;110:102374 [Crossref]

4- Lin E, Vincent F, Sahhar J, Ngian G, Kandane‐Rathnayake R, Mende R, Morand E, Lang T, Harris J. Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis. Clin & Trans Imm. 2019;8(4) [Crossref]

5- Nasonov E, Avdeeva A. Interleukin 18 in Immune-mediated rheumatic diseases and COVID-19. Naučno-praktičeskaâ revmatologiâ. 2022;60(2):195 [Crossref]

6- Zhang J, Liu X, Meng Y, Wu H, Wu Y, Yang B, Wang L. Autoimmune disease associated IFIH1 single nucleotide polymorphism related with IL-18 serum levels in Chinese systemic lupus erythematosus patients. Sci Rep. 2018;8(1) [Crossref]

7- Xue D, Qian Y, Tu X, He M, Xing F, Ren Y, Yuan C. The effect of circulating cytokines on the risk of systemic lupus erythematosus: Mendelian randomization and observational study. Immunogenetics. 2024;76(5-6):315 [Crossref]

8- Cao H, Liang J, Liu J, He Y, Ke Y, Sun Y, Jiang S, Lin J. Novel Effects of Combination Therapy Through Inhibition of Caspase-1/Gasdermin D Induced-Pyroptosis in Lupus Nephritis. Front Immunol. 2021;12 [Crossref]

9- Miteva L, Manolova I, Ivanova M, Stoilov R, Stanilova S. High interleukin-18 and low FOXP3 mRNAs in peripheral blood of women with severe systemic lupus erythematosus: a cross-sectional study. Rheumatol Int. 2020;40(5):727 [Crossref]

10- Saidov M. Autophagy, apoptosis, necroptosis, pyroptosis and netosis in pathogenesis of immune-inflammatory rheumatic diseases. Med immunol. 2022;24(4):659 [Crossref]

11- Su C, Wang I, Liu S, Sun Y, Jin L, Wang S, Lee H, Tseng W, Tang C. Hypoxia induced mitogenic factor (HIMF) triggers angiogenesis by increasing interleukin-18 production in myoblasts. Sci Rep. 2017;7(1) [Crossref]

12- Xiang M, Feng Y, Wang Y, Wang J, Zhang Z, Liang J, Xu J. Correlation between circulating interleukin-18 level and systemic lupus erythematosus: a meta-analysis. Sci Rep. 2021;11(1) [Crossref]

13- Colasanti T, Fiorito S, Alessandri C, Serafino A, Andreola F, Barbati C, Morello F, Alfè M, Di Blasio G, Gargiulo V, Vomero M, Conti F, Valesini G. Diesel exhaust particles induce autophagy and citrullination in Normal Human Bronchial Epithelial cells. Cell Death Dis. 2018;9(11) [Crossref]

14- Hirooka Y, Nozaki Y. Interleukin-18 in Inflammatory Kidney Disease. Front Med. 2021;8 [Crossref]

15- Liu G, Chen X, Wang Q, Yuan L. NEK7: a potential therapy target for NLRP3-related diseases. BST. 2020;14(2):74 [Crossref]

16- Ruchakorn N, Ngamjanyaporn P, Suangtamai T, Kafaksom T, Polpanumas C, Petpisit V, Pisitkun T, Pisitkun P. Performance of cytokine models in predicting SLE activity. Arthritis Res Ther. 2019;21(1) [Crossref]

17- Mende R, Vincent F, Kandane-Rathnayake R, Koelmeyer R, Lin E, Chang J, Hoi A, Morand E, Harris J, Lang T. Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus. Front Immunol. 2018;9 [Crossref]

18- Yang F, He Y, Zhai Z, Sun E. Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus. Journal of Immunology Research. 2019;2019:1 [Crossref]

19- Tang Y, Wang D, Chen Y, Xu W, Huang A. Th1-related transcription factors and cytokines in systemic lupus erythematosus. Front Immunol. 2023;14 [Crossref]

20- Alhussain A, Alquwayi W, Alkuwaiti Y, Almehainy A, Alkhathami ‏. Laboratory assessment of systemic lupus erythematosus. Int J of Health Sci. 2020;4(S1):248 [Crossref]

21- Gachpazan M, Akhlaghipour I, Rahimi H, Saburi E, Mojarrad M, Abbaszadegan M, Moghbeli M. Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview. Autoimmun Highlights. 2021;12(1) [Crossref]

22- Chen F, Liu X, Tao J, Mao Z, Wang H, Tan Y, Qu Z, Yu F. Renal NLRP3 Inflammasome activation is associated with disease activity in lupus nephritis. Clinical Immunology. 2023;247:109221 [Crossref]

23- Guo J, Xiang Y, Peng Y, Huang H, Lan Y, Wei Y. The association of novel IL-33 polymorphisms with sIL-33 and risk of systemic lupus erythematosus. Molecular Immunology. 2016;77:1 [Crossref]